Breast Cancer
Conference Coverage
PENELOPE-B: Palbociclib disappoints in HR+, HER2– breast cancer
Conference Coverage
Breast surgery may be a gateway to addictive medication use
More than 13% of women who underwent a mastectomy with reconstruction became persistent users of opioids and/or sedative-hypnotic drugs thereafter...
Conference Coverage
CTCs predict overall survival in metastatic breast cancer
New data seem to support using circulating tumor cells to assess treatment efficacy in practice, but an expert has doubts.
Article
NHS England starts pilot trial of blood test for many cancers
Patients with head and neck, pancreatic, and other hard-to-spot cancers could soon have their disease picked up early with a simple blood test if...
Conference Coverage
SABCS 2020: What’s hot, including a major chemotherapy trial
The world’s largest breast cancer meeting starts on Dec. 8.
News
Cancer rates on the rise in adolescents and young adults
News
Should CTCs guide treatment choice in HR+, HER2– breast cancer?
Survival outcomes were similar whether treatment choice was guided by circulating tumor cell counts or clinical factors.
News
Reduced cancer mortality with Medicaid expansion
There was a significant reduction in breast, colon, and lung cancer mortality.
News
New findings on ‘exceptional responders’ to cancer therapies
Why do a small percentage of cancer patients show exceptional responses to therapy? The answer may lie in their genetic makeup.
Conference Coverage
Immunotherapy could fill unmet need in leptomeningeal metastases
More than a third of patients had a CNS response to systemically administered pembrolizumab, including two patients who had long-lived complete...